Boston And Philadelphia 2022
Director: Ed Charlton
Ed Charlton is a Director and Owner of Alchemy Technology Services and has over 30 years of insurance technology experience.
Over the course of his career, Ed held various leadership positions where he led global insurance software strategy, commercialized and launched offerings, and managed software sales, implementation and support. Ed has also consulted with numerous software and technology companies and his background and knowledge of the insurance industry drives his passion to help companies implement focused and innovative solutions.
Alchemy Technology Services
Industry: Insurance Software Implementation Services (Insurtech)
Alchemy Technology Services is a global centre of excellence for insurance software implementation and professional services, supporting the digitisation of the insurance industry. They provide highly skilled talent and expertise needed to progress the modernisation and growth of technology platforms. Alchemy work with medium and large businesses in the insurance, financial and technology sectors. They offer a full lifecycle approach from software implementation, BAU, consultancy and project management, their unique working culture and working model makes them a natural choice for progressive transformative organisations, SIs and technology companies. The CEO and Founder, John Harkin, set up the company in 2018 and has been shortlisted for EY Ireland Entrepreneur of the Year Award 2022.
Trade Mission Objectives: To meet with insurance companies that either presently use or who are planning to transition to, the Guidewire or Insurity platforms. To meet with industry contacts who may be access partners to target insurers. Also learn more about the requirements and strategies for setting up a US subsidiary.
Mission delegate: Ed Charlton, EJC Consulting and partner of Alchemy
Director: Aaron Peace
Professor Peace is a practicing Cardiologist, and Director of Research and Development at the Western Health and Social Care Trust. He is a Visiting Professor to Ulster University Personalised Medicine Centre (PMC) and clinical lead for the Cardiovascular Research Group. He trained in Queen’s University, Belfast before working in Sydney, Australia and then Dublin where he undertook his Cardiology training. He was awarded a Health Research Board Clinical Fellowship and completed his PhD in platelet biology. He completed an Interventional Fellowship in OLV, Aalst, Belgium before moving back to Northern Ireland.
Professor Peace is a member of the Health and Social Care Northern Ireland (NHS NI) Digital Innovation Steering Group, the Northern Ireland Trusted Research Environment Steering Committee and Deputy Chair of the Honest Broker Governance Committee that provides governance and access to all healthcare data contained in the Northern Ireland data warehouse. He is a member of the Editorial Board of the European Heart Journal – Digital Health and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) – Innovations and Digital Cardiology Committee. He reviews for many international peer review journals and is a Fellow of the Royal College of Physicians and the European Society of Cardiology. Professor Peace is the CEO of C-TRIC, a non-for-profit company that facilitates clinical research for industry and academic investigators in partnership with clinicians. His special interests include cardiovascular risk prediction using Artificial Intelligence, Omics, and Digital Healthcare.
Industry: Clinical Research Organisation (CRO)
C-TRIC is a not-for-profit clinical research facility based at Altnagelvin Hospital, the second largest acute hospital in Northern Ireland. C-TRIC facilitates translational and clinical research by providing specialist workspaces and tailored services for academic researchers, clinical researchers and life and health science companies. C-TRIC has a 10+ year history of working with companies to test and validate their innovations bringing them from the laboratory to the patient’s bedside. All C-TRIC services are run by fully qualified scientists that can take a project from conception to publication. These include human factor studies, comparative & participative studies for medical devices, in vitro-in vivo specialist work and a “first in all-Ireland” single-cell multi-omics workflow. In addition, C-TRIC offers laboratory access, access to NHS consultants, doctors, research nurses and allied health professionals and study support officers.
C-TRIC is a key stakeholder in the city’s Personalised Medicine Centre (PMC). This project will provide leading capability in data analytics, biomarker discovery and medtech development, along with the capacity to perform robust clinical trials and business support to commercialise and implement new diagnostic tests, drugs, and technologies. The Personalised Medicine Centre will create a new healthcare quarter, Healthcare Research Institute and support a community-owned health research company.
Trade Mission Objectives: Our location is the first port of call for access into the UK and European market simultaneously. Therefore, our objective is to meet with life science companies with CRO needs, particularly those looking to sell into the UK National Health Service (NHS) and the wider European Union market. We aim to meet with other research organisations (US based CROs, universities and others) for potential partnerships. We want to learn more about the US healthcare and insurance industries in the fields of single-cell multi-omics and pharmacogenomics, focusing on cardiology and mental health.
Mission delegate: Professor Aaron Peace, CEO of C-TRIC, Research & Development Director of the Western Health & Social Care Trust and Consultant Cardiologist with Altnaglevin Hospital, Derry.
Director: Jim & Brian
Run by brothers in law and long-standing friends Brian and Jim, who are passionate about maintaining the long history of independent, traditional and craft distilleries in Ireland.
This engaging duo are particularly proud of this tradition in Northern Ireland where they are the first in 100-years to revive Irish Whiskey production in the north-western region.
Wild Atlantic Distillery
Wild Atlantic Distillery is an award-winning whiskey, gin and vodka distillery based in County Tyrone that draws its inspiration from Ireland’s spectacular rugged coastline. The distillery is located on the outskirts of the charming rural village of Aghyaran (Castlederg) close to the dramatic landscape of theSperrin Mountains and just 15 miles from the wild beaches on Ireland’s north-western coast.
Trade Mission Objectives: To meet with potential buyers of their vodka and gin (today) and eventually whiskey. To meet with importers/distributors to support US customers. To meet with local distillers in USA to share insights and explore potential partnerships.